RT @Vasculitis2022: There was a story building about cytokine storm in COVID-19 and use of tocilizumab https://t.co/hu4mectNCn #Vasculit…
There was a story building about cytokine storm in COVID-19 and use of tocilizumab https://t.co/hu4mectNCn #Vasculitis22 https://t.co/3zsyFdSZBN
@JamiePruden1 @AKRule @Holbornlolz Matt Hancock was recently talking up the beneficial effect of some anti-arthritis drugs for treating ICU Covid patients. Chinese doctors found out it was effective in April last year. Why did UK wait so long? https://t.c
@MMMalign @QueenOfTheWilis Ivermectin, Tocilizumab and, hydroxychloroquine are all prescribed to help rheumatoid arthritis Tocilizumab can sometimes trigger M.S. when used for R.A. its weird https://t.co/Rwx0jwJ5la Some success back in april for that one
RT @richardinnes1: tocilizumab is the drug I would want if I got severe Covid!! https://t.co/7IMnmoMuDJ
12-9-2020: In a clinical trial just released today from Wuhan, China, good news for Actemra for treating 65☣COVID-19☣patients☣ Thank the 130☠fake Actemra☠ https://t.co/fJfWfqvKIs https://t.co/J5YC6tMYq7 https://t.co/Y7GYgbG0Y7 https://t.co/NvDBKzaecR http
RT @drcekic: @Medimagazin Sitokin fırtınası için tocilizumab baya etkili, kullanımının yaygınlaştırılması lazım https://t.co/UdR1dwCQJI
@Medimagazin Sitokin fırtınası için tocilizumab baya etkili, kullanımının yaygınlaştırılması lazım https://t.co/UdR1dwCQJI
5-27-2020: In a 181-patient clinical trial just released today from China, good news for Actemra (tocilizumab) for treating 92 COVID-19 patients, thank the 89: https://t.co/3MijBO7Tfn https://t.co/J5YC6tMYq7 https://t.co/Y7GYgbG0Y7 https://t.co/NvDBKzaecR
@BojackRemy @AlfredoLopPce @PlALBERTO @icaza_alvarez @clastrac Ve este estudio en China. https://t.co/O1LVlfoeXY
@MBittencourtMD O que me diz sobre esse estudo em pacientes graves ? https://t.co/uTEEIQRmuH
RT @alainjasaf: https://t.co/JJ5fsARwX6 Puede que sea útil para covid19 pero con este tipo de estudios es imposible demostrarlo . Excelent…
@elsolde_mexico La revista PNAS no publica artículos sin evidencia científica sólida. No es un medicamento nuevo al que haya que temer por los efectos secundarios. El tiempo apremia. Aquí el artículo: https://t.co/qbZC6drsP2
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
RT @Humberto_R_: @DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artícul…
@DrPacoMoreno1 @lopezobrador_ @COFEPRIS Muy buena noticia. Gracias por insistir en este punto, Dr. Moreno. Aquí el artículo científico en PNAS: https://t.co/qbZC6drsP2
No es una cura, pero sin duda es una importante herramienta para combatir la enfermedad. Anexo artículo sobre la efectividad del tocilizumab https://t.co/lz6fJgt6pg
No es una cura, pero sin duda es una importante herramienta para combatir la enfermedad Anexo artículo de un estudio sobre el tociluzimab: https://t.co/lz6fJgt6pg
@apostolosz Να πούμε γι' αυτό το φάρμακο, μάλιστα! Με τρανταχτά στοιχεία η πρόοδος! https://t.co/s5pojGAMBW
RCTs are in progress but #Tocilizumab could well be beneficial in #COVID19 hyperinflamm, however… 2/ https://t.co/abM82euBDy
Effective treatment of severe COVID-19 patients with tocilizumab https://t.co/DIuxLG5y4V
RT @hichachu: https://t.co/UniA1MmNiI 発熱は初日から正常に戻り、その他の症状は数日で著しく改善した。トシリズマブ後5日以内に20人の患者のうち15人(75.0%)が酸素摂取量を低下させ、1人の患者は酸素療法を必要としなかった。CTスキャンに…
RT @hichachu: https://t.co/UniA1MmNiI 発熱は初日から正常に戻り、その他の症状は数日で著しく改善した。トシリズマブ後5日以内に20人の患者のうち15人(75.0%)が酸素摂取量を低下させ、1人の患者は酸素療法を必要としなかった。CTスキャンに…
RT @hichachu: https://t.co/UniA1MmNiI 発熱は初日から正常に戻り、その他の症状は数日で著しく改善した。トシリズマブ後5日以内に20人の患者のうち15人(75.0%)が酸素摂取量を低下させ、1人の患者は酸素療法を必要としなかった。CTスキャンに…
https://t.co/UniA1MmNiI 発熱は初日から正常に戻り、その他の症状は数日で著しく改善した。トシリズマブ後5日以内に20人の患者のうち15人(75.0%)が酸素摂取量を低下させ、1人の患者は酸素療法を必要としなかった。CTスキャンにより19人の患者(90.5%)で肺病変の混濁が吸収された。治療前の患者の
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
The pandemic effects and patient-focused precautions in Hem-Onc units during COVID-19. https://t.co/qcZdJBZyoq https://t.co/xn1o5bI1Op
RT @MDedgeHemOnc: The pandemic effects and patient-focused precautions in Hem-Onc units during COVID-19. https://t.co/mld6D8ZDFE https://t…
The pandemic effects and patient-focused precautions in Hem-Onc units during COVID-19. https://t.co/mld6D8ZDFE https://t.co/x2FDqB7K42
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
JAJAJAJA
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
RT @traumacito: Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https:…
Remdesivir: https://t.co/9rRbaYGT87 Plasma convalesciente: https://t.co/iInFr3MCXk Lopinavir/Ritonavir + Interferon: https://t.co/hgFh469909 Inhibidores del complemento: https://t.co/Ojr4vI0DW5 Tocilizumab: https://t.co/TA6F04clC7 Hidroxicloroquina: todos
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @Jeff_Mold: @VPrasadMDMPH @Edit0r_At_Large What Did you think about this one? I was shocked it didn’t make more headlines : https://t.…
@VPrasadMDMPH @Edit0r_At_Large What Did you think about this one? I was shocked it didn’t make more headlines : https://t.co/dJ6Aj6Ga5V
Uhhh Why was this not more widely reported? https://t.co/dJ6Aj6Ga5V
@pandanx12 @mallen020202 @Yamiche Do you know the other IL-6 blocker, Actemra (Tocilizumab)? It was making news saving doctors from death for a couple months now. Genentech might complete the whole study this month. It could change things for severe patien
@RapalloCarlos It’s incredible! What kind of conclusion can you draw from this type of study? Nothing useful! https://t.co/Ok2dDpwpXK
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
https://t.co/JJ5fsARwX6 Puede que sea útil para covid19 pero con este tipo de estudios es imposible demostrarlo . Excelente medicamento para ar y arteritis de células gigantes . #tocilizumab @drpaolandmd https://t.co/wg5csIAe4d
RT @slman144m7: نشرت الأكاديمية الأمريكية للعلوم (PNAS) نتائج تجربة سريرية مصغرة لدواء (Tocilizumab) بمشاركة 21 مريضاً بالفيروس التاجي (كور…
نشرت الأكاديمية الأمريكية للعلوم (PNAS) نتائج تجربة سريرية مصغرة لدواء (Tocilizumab) بمشاركة 21 مريضاً بالفيروس التاجي (كورونا)، وكانت النتائج تفيد بأن الدواء أستطاع إيقاف تدهور حالة المرضى، وساعد في تحسن حالتهـم .. ما يمهـد له الطريق لأن يكون (العلاج) ! h
It is a small clinical study (n=21 patients), and we need to be cautious, but it seems that #tocilizumab could be an efficient therapy for the treatment of #COVID19. https://t.co/m6ZZ3l6KEA
RT @wsleal2014: And Dr. @AtulMalhotra13 one of the leading PIs in a large clinical trial in the US will be speaking in our Second COVID-19…
RT @wsleal2014: And Dr. @AtulMalhotra13 one of the leading PIs in a large clinical trial in the US will be speaking in our Second COVID-19…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
I am reading so many of these articles recently that I have started to feel the urge to brush off on my immunology.
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
IL-6 blockers still in the running as treatment for severe cv
And Dr. @AtulMalhotra13 one of the leading PIs in a large clinical trial in the US will be speaking in our Second COVID-19 Symposium this Thu at 1:30 PM PDT. For registration, https://t.co/JQfGJhKtDW Other panelists are @DrABrashear @MaverakisLab @dlubarsk
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
#Tocilizumab immediately improved the clinical outcome in severe and critical #COVID19 patients, and may be an effective treatment to reduce #coronavirus deaths @PNASNews https://t.co/h3QS7Zghh1
#MIMG102XL Last week I briefly mentioned anti COVID19 strategies targeting the immune system instead of the of the virus. Here are the results of such approach:
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
RT @PNASNews: Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment f…
Tocilizumab, an antibody that binds to the IL-6 receptor and prevents IL-6 signaling, might represent an antibody treatment for severe #Covid19, a study finds. In PNAS: https://t.co/o8SX7Fsmnc https://t.co/CdukiL9yL8
@RZarychanski
RT @sanchak74: @chitguppi This is exactly what I have been suggesting - using Nanopore (reference 5) would be the best - cheap and fast. T…
RT @sanchak74: @chitguppi This is exactly what I have been suggesting - using Nanopore (reference 5) would be the best - cheap and fast. T…
RT @sanchak74: @chitguppi This is exactly what I have been suggesting - using Nanopore (reference 5) would be the best - cheap and fast. T…
RT @sanchak74: @chitguppi This is exactly what I have been suggesting - using Nanopore (reference 5) would be the best - cheap and fast. T…
@chitguppi This is exactly what I have been suggesting - using Nanopore (reference 5) would be the best - cheap and fast. This is April 24th paper - no one seems to be paying heed to this. This paper I just saw https://t.co/WtwBSSwYXj "No emerging bacter
RT @DanielleFong: Good news out of Shanghai Jiao Tong University, Published in the Peer Reviewed (and very prestigious) Proceedings of the…
Good news out of Shanghai Jiao Tong University, Published in the Peer Reviewed (and very prestigious) Proceedings of the National Academy of Sciences of the USA Effective treatment of *severe* COVID patients with tocilizumab. Fights cytokine storm! http
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
RT @ivanoransky: TL;DR version: No control group. "Preliminary data show that tocilizumab, which improved the clinical outcome immediately…
This is the key, guys. Same mechanism of action as Singulair. BLOCK THE CYTOKINES
RT @greg_folkers: .@PNASNews PNAS: Effective treatment of severe #COVID19 patients with tocilizumab https://t.co/6fSuvMQL7T
RT @greg_folkers: .@PNASNews PNAS: Effective treatment of severe #COVID19 patients with tocilizumab https://t.co/6fSuvMQL7T
RT @greg_folkers: .@PNASNews PNAS: Effective treatment of severe #COVID19 patients with tocilizumab https://t.co/6fSuvMQL7T
RT @greg_folkers: .@PNASNews PNAS: Effective treatment of severe #COVID19 patients with tocilizumab https://t.co/6fSuvMQL7T